November 29, 2021

Lucira Health, Inc. (LHDX) experienced an incline of 3.30% in the premarket following the news that Lucira at-home Test Kits can detect Omicron. However, the last trading session concluded at $6.98 with an incline of 15.56%. LHDX All-In-One Test Kits – Is it the truth? LHDX announced on 29th November 2021 that Lucira Test Kits […]

Adagio Therapeutics, Inc. (ADGI) experiences an amazing incline of 31.41% in the premarket. However, the last trading session closed at $25.12 with an increase of 34.12%. Omicron SARS-CoV-2 variant – What’s up? On 29th November 2021, ADGI gave details on the ability of its leading SARS-CoV-2 antibody, ADG20. This will help combat the Omicron SARS-CoV-2

Viemed Healthcare, Inc. (VMD) saw a push of 5.16% in the premarket. However, the last trading session closed at $5.23 with a decrease of 3.15%. Third Quarter 2021 Results by VMD– How was the quarter? VMD announced third quarter 2021 results on 1st November 2021. According to the report, total net revenues came out to

NRx Pharmaceuticals, Inc. (NRXP) stock declined by 2.81% to reach $6.56 in the pre-market. The stock gained a value of 30% in the last 5 days. At the end of the last trading session, the stock closed at $4.50. The average volume of stock traded in the trading session was 3.47 million. Reasons for the

Moderna Inc. (MRNA) went up by a further 9.40% in the premarket, at $369.60, against its previous close at $329.63 on November 26. In the previous trading session, the stock gained 20.57% at a volume of 35.9 million. Which was 282% of the stock’s 65-day average volume of 12.75 million. Intraday trading, MRNA moved between

180 Life Sciences Corp. (ATNF) saw an amazing push of 19.78% in the premarket. However, the last trading session closed at $5.41 with an increase of 21.3%. Patent Portfolio Expanded by ATNF – What’s going on? ATNF announced on 22nd November 2021 that the company has expanded its patent portfolio. Patients with established rheumatoid arthritis

Tonix Pharmaceuticals Holding Corp. (TNXP) went up by 8.32% in the premarket, at $0.55 with 137 thousand shares exchanging at the last check. In the previous market session, the stock gained 6.18% to close at $0.5050 on November 26. Intraday trading, the stock went up to $0.51 and down to $0.48 at a volume of

Biofrontera Inc. (BFRI) has experienced a decline of 1.14% in the aftermarket. However, the last trading session closed at $7.9 with an increase of 51.34%. BFRI to report Third Quarter Results 2021 – What’s the schedule? BFRI announced on 23rd November 2021 that the company will report the third quarter 2021 results on 30th November